Stay updated with breaking news from Immunisation Practices. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WASHINGTON, June 26 ― The US drug regulator yesterday added a warning to the literature that accompanies Pfizer Inc /BioNTech and Moderna Covid vaccine shots to indicate the rare risk of heart inflammation after its use. For each vaccine, the fact sheets for healthcare providers have been revised...
WASHINGTON - The US drug regulator on Friday (June 25) added a warning to the literature that accompanies Pfizer Inc-BioNTech and Moderna Covid-19 vaccine shots to indicate the rare risk of heart inflammation after its use. For each vaccine, the fact sheets for healthcare providers have been revised to include a warning that reports of adverse events suggest increased risks...
The median age of patients who experienced the inflammation after a second vaccine dose was 24.. Read more at straitstimes.com.
Written by rjs, MarketWatch 666The news posted last week for the coronavirus 2019-nCoV (aka SARS-CoV-2), which produces COVID-19 disease, has been surveyed and some important articles are summarized here. The articles are more or less organized with general virus news and anecdotes first, then stories from around the US, followed by an increased number of items from other countries around the globe. Economic news related to COVID-19 is found here.
Moderna says its COVID-19 vaccine 100 per cent effective in 12-17 age group Representative Image WASHINGTON [US]: Moderna on Tuesday announced that various studies have shown its COVID-19 vaccine was 100 per cent effective at preventing infection in adolescents aged 12 to 17 and it planned on submitting the findings to global regulators in days. “We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents. It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection,” Moderna CEO Stephane Bancel said in the announcem...